NEW YORK, April 11 - The US government has awarded Cepheid a patent for its I-CORE technology, which allows for "simultaneous, real-time optical excitation and detection of two or more nucleic acids," and one for a technology that allows for the "automated preparation of biological samples using chip-based microfluidics technology."

To date, Cepheid has 36 US patents either issued or pending, plus corresponding foreign patent applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.